338 related articles for article (PubMed ID: 14606048)
1. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of neurofibromatosis type 1].
Lozada Y; Alvarez-Valiente H; Argüelles M
Rev Neurol; 1998 Nov; 27(159):792-5. PubMed ID: 9859153
[TBL] [Abstract][Full Text] [Related]
3. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
4. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
[TBL] [Abstract][Full Text] [Related]
6. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis type 1: a survey of 195 patients].
Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
12. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
[TBL] [Abstract][Full Text] [Related]
13. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
[TBL] [Abstract][Full Text] [Related]
14. [Developmental manifestation in children with neurofibromatosis type 1].
Cohen R; Shuper A
Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
Lammert M; Friedman JM; Kluwe L; Mautner VF
Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
[TBL] [Abstract][Full Text] [Related]
16. Associations of clinical features in neurofibromatosis 1 (NF1).
Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
[TBL] [Abstract][Full Text] [Related]
17. Natural history and outcome of optic pathway gliomas in children.
Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
[TBL] [Abstract][Full Text] [Related]
18. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis type 1 in children--with special consideration of ophthalmologic symptoms].
Kósa E; Csákváry V
Orv Hetil; 2004 Feb; 145(9):473-8. PubMed ID: 15077479
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
Odebode TO; Afolayan EA; Adigun IA; Daramola OO
Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
